{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:22:15Z","timestamp":1784694135886,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.cgh.2010.10.022","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T08:22:05Z","timestamp":1289290925000},"page":"130-136.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging"],"prefix":"10.1016","volume":"9","author":[{"given":"Konstantinos","family":"Karmiris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vanbeckevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Coremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rutgeerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Van Assche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2010.10.022_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn's disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.10.022_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor: biology and therapeutic inhibitors","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.10.022_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ibd.21026","article-title":"Etiology of perianal Crohn's disease: role of genetic, microbiological and immunological factors","volume":"15","author":"Tozer","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2010.10.022_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulae in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2010.10.022_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2010.10.022_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.2008.155812","article-title":"Long-term outcome of treatment with infliximab in 614 Crohn's disease patients: results from a single center cohort","volume":"58","author":"Schnitzler","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.10.022_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gut.36.3.407","article-title":"Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging","volume":"36","author":"Haggett","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2010.10.022_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1148\/radiol.2391041043","article-title":"Imaging of fistula in Ano","volume":"239","author":"Halligan","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2010.10.022_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.10.022_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2036.2003.01427.x","article-title":"Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.10.022_bib11","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.10.022_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10350-004-6111-6","article-title":"Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response","volume":"45","author":"Van Bodegraven","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"Suppl A","key":"10.1016\/j.cgh.2010.10.022_bib13","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.10.022_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.1800630102","article-title":"A classification of fistula-in-ano","volume":"63","author":"Parks","year":"1976","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2010.10.022_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2001.28676","article-title":"A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas","volume":"121","author":"Schwartz","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.10.022_bib16","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s10620-008-0545-y","article-title":"Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease","volume":"54","author":"Tougeron","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2010.10.022_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2214\/ajr.178.3.1780737","article-title":"Anovaginal and rectovaginal fistulas: endoluminal sonography versus endoluminal MR imaging","volume":"178","author":"Stoker","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2010.10.022_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/BF02054416","article-title":"Magnetic resonance imaging of fistula-in-ano","volume":"37","author":"Lunnis","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2010.10.022_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1572-0241.2004.04083.x","article-title":"Type of fistula determines response to infliximab in patients with fistulous Crohn's disease","volume":"99","author":"Parsi","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.10.022_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.2002.35390","article-title":"Predictors of response to infliximab in patients with Crohn's disease","volume":"123","author":"Parsi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2010.10.022_bib21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1365-2036.2003.01574.x","article-title":"An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease","volume":"17","author":"Arnott","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2010.10.022_bib22","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1111\/j.1572-0241.2002.05991.x","article-title":"Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease","volume":"97","author":"Vermeire","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2010.10.022_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF02237196","article-title":"Prognostic value of magnetic resonance imaging in the management of fistula-in-ano","volume":"43","author":"Chapple","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2010.10.022_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2214\/ajr.171.2.9694464","article-title":"Outcome after surgery for perianal fistula: predictive value of MR imaging","volume":"171","author":"Spencer","year":"1998","journal-title":"AJR Am J Roentgenol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510010876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356510010876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:06:32Z","timestamp":1761541592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356510010876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1542356510010876"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2010.10.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2010.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}